Telehealth Narcolepsy Prescribing: What Prescribers Can Do in Pennsylvania

You’ve spent years building your expertise in psychiatric care. You know how to manage complex medication regimens, navigate patient psychology, and handle the administrative maze of modern practice. But narcolepsy? That’s the patient who comes in desperate after their third car accident, the one who’s been told by five providers ‘I don’t treat that,’ the one whose sleep specialist can’t see them for eight months.

Here’s what most psychiatrists and PMHNPs don’t realize: you’re already equipped to treat narcolepsy patients via telehealth — and there’s massive unmet demand. Roughly 160,000 Americans have narcolepsy, but most struggle to find providers who understand both the condition and the controlled-substance regulations involved. If you can prescribe stimulants for ADHD, you can manage narcolepsy medications. The real question isn’t ‘Can I do this?’ but rather ‘What are the legal guardrails, and how do I make it work in my state?’

Let’s cut through the regulatory fog and talk about what psychiatrists and PMHNPs can actually do in telehealth narcolepsy care in 2026.

Understanding Narcolepsy: Why Psychiatrists Are Well-Positioned to Help

Narcolepsy isn’t just excessive daytime sleepiness. It’s a neurological disorder where the brain can’t regulate sleep-wake cycles properly, often causing sudden ‘sleep attacks’ (falling asleep mid-conversation), cataplexy (sudden muscle weakness triggered by emotion), vivid hallucinations when falling asleep, and sleep paralysis. Prevalence is about 1 in 2,000 people — rare enough that most PCPs don’t manage it, but common enough that you’ll see these patients if you’re practicing telepsychiatry.

Why do narcolepsy patients end up seeing psychiatrists? Several reasons:

• Stimulant expertise: The first-line treatment is often methylphenidate (Ritalin) or amphetamines (Adderall) — medications you’re already familiar with from ADHD management
• Comorbid psychiatric conditions: Depression, anxiety, and ADHD frequently co-occur with narcolepsy (partly because chronic sleep disruption wreaks havoc on mental health)
• Access barriers: Sleep specialists are scarce, especially in rural areas, and wait times can stretch 6-12 months
• Medication complexity: These patients often need polypharmacy (a stimulant for daytime alertness, possibly sodium oxybate for cataplexy, sometimes an SSRI), which requires the kind of medication management psychiatrists excel at

From a clinical standpoint, if you can manage bipolar disorder medication or complicated ADHD cases, narcolepsy is within your wheelhouse. The diagnostic workup (polysomnogram with Multiple Sleep Latency Test) is typically done by a sleep specialist, but once diagnosis is confirmed, ongoing medication management is straightforward psychiatric pharmacotherapy.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Federal Telehealth Rules: The Current Landscape (2025-2026)

Let’s start with the federal framework, because this is what confuses most providers.

DEA Telemedicine Flexibility (Extended Through End of 2025)

During COVID-19, the DEA suspended the Ryan Haight Act’s requirement that providers conduct an in-person medical evaluation before prescribing controlled substances via telemedicine. As of late 2024, the DEA and HHS extended this waiver through the end of 2025, meaning:

• You can initiate Schedule II-V controlled substances (including stimulants like Adderall, modafinil, methylphenidate) via video-only telehealth visit
• No initial in-person exam is required for new patients
• You must still be licensed in the patient’s state and comply with all state telemedicine laws

What happens after December 2025? Nobody knows for certain. The DEA has proposed new telemedicine registration rules that would allow ‘special registration’ for telehealth prescribing, potentially making the flexibility permanent. However, they could also revert to requiring in-person exams. As a provider, you should:

1. Monitor DEA announcements throughout 2025
2. Have contingency plans (partnerships with local physicians who could do in-person exams if needed)
3. Document the medical necessity and standard-of-care equivalence of your telehealth evaluations

Bottom line for now: You can legally prescribe narcolepsy stimulants entirely via telehealth through 2025, as long as you meet all other federal and state requirements.

Psychiatrist Scope of Practice: No Restrictions (With Smart State Compliance)

If you’re a board-certified psychiatrist (MD or DO), you have full authority to diagnose and treat narcolepsy in all 50 states — assuming you’re licensed in the patient’s state and follow federal controlled-substance rules.

What Psychiatrists Can Do via Telehealth for Narcolepsy:

Initial Evaluation:

• Review prior sleep study results (polysomnography/MSLT) to confirm diagnosis
• Take comprehensive history of sleep symptoms, accidents, functional impairment
• Rule out alternative causes (sleep apnea, medication side effects, depression)
• Assess comorbid psychiatric conditions (very common with narcolepsy)
• Order labs if needed (liver function if considering certain medications)

Medication Management:

• Initiate first-line stimulants: Modafinil (Schedule IV), armodafinil (Schedule IV), methylphenidate (Schedule II), amphetamine/dextroamphetamine (Schedule II)
• Prescribe newer agents: Solriamfetol (Sunosi), pitolisant (Wakix) for patients who don’t respond to traditional stimulants
• Manage cataplexy: Sodium oxybate (Xyrem/Xywav — Schedule III with REMS program), or off-label antidepressants (venlafaxine, SSRIs)
• Titrate doses: Monthly follow-ups during dose optimization, then quarterly for stable patients
• Monitor side effects: Blood pressure, heart rate, weight, mood changes
• Address tolerance: Dose adjustments, medication holidays, switches between stimulants

Ongoing Care:

• Monthly 15-20 minute video visits for medication checks (billable as 99213/99214)
• PDMP checks before each controlled-substance prescription
• Coordinate with sleep specialists or PCPs for annual sleep study reviews
• Write letters for workplace/academic accommodations

State-Specific Considerations for Psychiatrists:

While your scope of practice doesn’t vary by state, telehealth prescribing laws do. Here are the key restrictions:

Florida: State law prohibits prescribing Schedule II controlled substances via telehealth unless the patient has a psychiatric disorder. Since narcolepsy is neurological (not psychiatric), you technically cannot prescribe Adderall via pure telehealth for narcolepsy in Florida — but you can prescribe modafinil (Schedule IV, which is allowed). If the patient also has ADHD or another psychiatric diagnosis, the psychiatric exception may apply. Conservative approach: use Schedule IV agents or require at least one in-person visit.

Texas: No physician-specific telehealth restrictions on controlled substances. As long as you establish a valid practitioner-patient relationship via video and meet standard-of-care requirements, you can prescribe narcolepsy medications via telehealth.

California, New York, Illinois, Pennsylvania: No state-level barriers to psychiatrists prescribing narcolepsy medications via telehealth. Standard telemedicine rules apply (video visit, documentation, PDMP checks).

All states require:

• Active medical license in the patient’s state
• DEA registration (either in that state or via federal provisions)
• Use of state PDMP before prescribing controlled substances
• Electronic prescribing (EPCS) for controlled substances
• Audio-visual communication for initial evaluations (no phone-only)

PMHNP Scope: State-by-State Authority Differences

This is where it gets complicated. Nurse practitioners’ ability to treat narcolepsy independently varies dramatically by state.

Full-Practice States (PMHNPs Can Practice Independently After Experience):

New York:

• New NPs (less than 3,600 hours): Need written collaborative agreement with physician; can prescribe narcolepsy meds if protocol includes them
• Experienced NPs (3,600+ hours): Fully independent — no collaborative agreement needed, can prescribe all narcolepsy medications including Schedule II stimulants
• Telehealth: No restrictions; experienced PMHNPs can manage narcolepsy entirely via video visits

Illinois:

• Full Practice Authority NPs (4,000 hours + 250 CE hours): Can prescribe narcolepsy medications independently
• Note: Illinois law requires physician consultation for Schedule II opioids and long-term benzodiazepines — but not for stimulants
• New NPs: Need collaborative agreement; physician must delegate Schedule II authority in writing
• Telehealth: No state barriers; FPA-certified PMHNPs function like psychiatrists

California:

• Current status (2025-early 2026): NPs must practice under standardized procedures with physician oversight (‘103 NP’ category)
• January 2026 onward: NPs with 3+ years as 103 NPs can become fully independent ‘104 NPs’
• Schedule II prescribing: Allowed with physician protocol (currently); will be fully independent for 104 NPs
• Telehealth: Permitted; AB 890 independent NPs can manage narcolepsy remotely

Restricted-Practice States (PMHNPs Need Physician Supervision):

Texas:

• All NPs must have Prescriptive Authority Agreement with supervising physician
• Critical limitation: Texas law prohibits NPs from prescribing Schedule II drugs to outpatients except in hospital settings or hospice care
• This means Texas PMHNPs cannot prescribe Adderall, Ritalin, or other Schedule II stimulants for narcolepsy patients in outpatient/telehealth settings
• They can prescribe modafinil, armodafinil (Schedule IV) and other non-Schedule II options
• Practical solution: NP-MD team model where supervising psychiatrist writes Schedule II prescriptions, NP handles follow-ups and Schedule III-V meds
• Telehealth: Allowed under supervision

Florida:

• All PMHNPs need collaborative agreement with psychiatrist (psychiatric NPs were excluded from Florida’s autonomous practice law)
• Schedule II limit: NPs can only prescribe 7-day supply of Schedule II drugs (unless certified ‘psychiatric nurse’ treating psychiatric condition)
• For narcolepsy (non-psychiatric), this means weekly prescriptions — highly impractical
• Practical solution: Use modafinil/armodafinil (Schedule IV, no quantity limit) or have collaborating psychiatrist handle stimulant prescriptions
• Telehealth: Schedule III-V allowed; Schedule II restricted unless psychiatric diagnosis

Pennsylvania:

• All NPs need collaborative agreement with physician
• Schedule II limit: NPs can prescribe up to 30-day supply (must notify physician within 24 hours)
• More workable than Florida’s 7-day limit; aligns with monthly follow-up best practice
• Schedule III-IV: Up to 90-day supply
• Telehealth: No state restrictions beyond collaboration requirement

Key Takeaway for PMHNPs:

If you’re in NY, IL, or CA (after 2026) with full practice authority, you can manage narcolepsy patients nearly identically to psychiatrists via telehealth.

If you’re in TX, FL, or PA, you’ll need creative collaboration models:

• Partner with supervising psychiatrist who can write Schedule II prescriptions
• Focus on patients who respond to Schedule IV alternatives (modafinil)
• Use telehealth for follow-ups, with physician handling initial stimulant prescriptions

Practical Workflow: How to Actually Do This

Patient Onboarding:

1. Verify diagnosis: Request sleep study reports (polysomnography with MSLT showing sleep latency <8 minutes and/or cataplexy)
2. Initial video evaluation (30-45 minutes):

• Comprehensive psychiatric history
• Sleep symptom review (Epworth Sleepiness Scale)
• Medication history and prior treatment attempts
• Comorbid conditions screening
• Functional assessment (driving safety, work/school impact)

1. PDMP check: Required before any controlled-substance prescription
2. Prescribe initial medication:

• Many start with modafinil 200mg QAM (Schedule IV, fewer restrictions)
• Or methylphenidate 10mg BID if patient needs stronger effect
• E-prescribe using EPCS-enabled system

1. Patient education:

• Medication expectations (often takes 2-4 weeks to optimize dose)
• Side effect monitoring (blood pressure, appetite, sleep at night)
• Safety counseling (no driving if experiencing sleep attacks)
• Sleep hygiene (scheduled naps, consistent sleep schedule)

Follow-Up Schedule:

• Weeks 2-4: Video check-in (15 min) to assess response, adjust dose
• Monthly during titration phase (usually 2-3 months)
• Quarterly once stable (15-20 min medication checks)
• Annual comprehensive evaluation and review of sleep study results

Billing:

• Initial evaluation: 99204 or 99205 (new patient E/M)
• Follow-ups: 99213 (15 min) or 99214 (25 min) based on complexity
• Telehealth modifier as required by payer
• Most commercial insurance and Medicare reimburse at parity with in-person visits

Documentation Essentials:

• Date/time, patient location (for state licensure compliance)
• Clinical rationale for controlled-substance prescription
• PDMP check documentation
• Informed consent for telehealth and controlled substances
• Symptom severity scores (Epworth, sleep diary data)
• Side effect screening
• Functional outcomes

Common Clinical Scenarios and How to Handle Them

Scenario 1: Patient on Adderall 30mg BID, Switching to Telehealth

Approach:

• Verify diagnosis with prior records
• Continue current regimen if stable (no need to taper and restart)
• Check PDMP (look for any concerning patterns)
• Monthly follow-ups as usual
• Coordinate with prior provider for transition of care documentation

Scenario 2: New Patient, Diagnosis Confirmed, Never Treated

Approach:

• Start conservative: Modafinil 100-200mg QAM (fewer abuse concerns, Schedule IV)
• Titrate based on response over 4-6 weeks
• If inadequate response, consider adding low-dose stimulant or switching to methylphenidate
• Educate about realistic expectations (meds reduce but don’t eliminate sleepiness)

Scenario 3: Patient Requesting Higher Doses, History of Stimulant Misuse

Red flags:

• Early refill requests
• Lost prescriptions
• Erratic PDMP patternApproach:
• Structured medication agreement
• More frequent visits (every 2 weeks)
• Consider switching to non-stimulant (Sunosi, Wakix)
• Pill counts via video (have patient show bottle)
• Coordinate with addiction specialist if needed
• Document everything meticulously

Scenario 4: State with NP Restrictions (Texas PMHNP)

Approach:

• Establish collaborative agreement with psychiatrist covering Schedule II delegation
• Manage patient with modafinil initially (NP can prescribe)
• If patient needs Schedule II stimulant, psychiatrist writes initial prescription
• NP handles all follow-ups, symptom monitoring, dose adjustments within scope
• Physician reviews cases monthly per Texas supervision requirements

The Medication Shortage Reality (and How to Navigate It)

Since mid-2022, there’s been a persistent Adderall shortage affecting narcolepsy patients nationwide. This isn’t going away quickly — DEA manufacturing quotas, supply chain issues, and demand surge have created ongoing scarcity.

What this means for you:

• Patients may call in panic when their pharmacy can’t fill prescriptions
• You’ll need flexibility to switch medications quickly (e.g., Adderall → methylphenidate → dextroamphetamine)
• Electronic prescribing helps (you can send to multiple pharmacies)
• Consider non-amphetamine alternatives: modafinil, armodafinil, Sunosi, Wakix

Pro tip: Educate patients upfront that they may need to call multiple pharmacies, and you’re willing to send prescriptions to wherever has stock. This proactive communication reduces panicked calls.

Reimbursement: What You’ll Actually Get Paid

Commercial Insurance:

• Telehealth parity laws in most states mean you’re paid the same as in-person
• Typical reimbursement for 99213 (15-min follow-up): $80-$120
• For 99214 (25-min complex visit): $110-$160
• Mental health providers often receive 22% less than other specialists — but narcolepsy can sometimes be billed under neurology codes (G47.4x), potentially better reimbursement

Medicare:

• Telehealth mental health visits covered at parity (through at least 2024, likely extended)
• MD reimbursement: 100% of fee schedule
• NP reimbursement: 85% of physician fee schedule
• Medicare allowable for 99214: ~$110-$130 (varies by locality)

Cash-Pay Alternative:

• Many narcolepsy patients are willing to pay out-of-pocket if it means accessing timely, expert care
• Typical cash rates: $200-$300 for initial evaluation, $75-$150 for follow-ups
• Subscription models work well (e.g., $150/month includes monthly visits and messaging access)

Hidden Cost: Prior Authorizations

• Narcolepsy medications (especially Xyrem, Sunosi, Wakix) often require extensive prior authorizations
• This is unpaid administrative work — budget 30-60 minutes per PA
• Some insurers require peer-to-peer calls (occasionally paid, usually not)
• Consider hiring support staff or using a platform that handles PA documentation

Annual revenue per narcolepsy patient (if stable, quarterly visits):

• 4 visits × $100 average = $400/year (insurance)
• OR monthly visits during titration: 12 visits × $100 = $1,200/year
• Cash-pay monthly subscription: $1,800/year

Multiply by 20-30 narcolepsy patients in your panel, and you’re looking at meaningful revenue with relatively short visit times.

Why This Makes Sense for Your Practice

Let’s talk economics honestly. Most psychiatrists are drowning in referrals for depression and anxiety — conditions where you’re competing with every other therapist, PMHNP, and primary care provider doing ‘med management.’ Insurance pays poorly, patients often need psychotherapy you may not want to provide, and burnout is real.

Narcolepsy is different:

High Demand, Low Competition

• Most psychiatrists say ‘I don’t treat that’ and refer to sleep specialists
• Sleep specialists have 6-12 month waits in many markets
• You become the solution to an acute access problem

Medication-Focused Care

• These are med management visits — no expectation of therapy
• Clear clinical protocols (start with modafinil, titrate stimulants, monitor side effects)
• Objective outcomes (Epsworth scores, functional measures)
• Patients are typically adherent (they desperately need the medication to function)

Efficient Visit Structure

• 15-20 minute follow-ups (vs. 45-60 min therapy sessions)
• Can see 3-4 patients per hour once panel is stable
• Low no-show rates (patients need their monthly scripts)
• Telehealth eliminates travel time for both you and patient

Predictable Panel

• Narcolepsy is chronic — patients stay in your practice for years
• Monthly or quarterly regular visits (steady income)
• Low turnover compared to acute psychiatric care

Intellectual Interest

• You’re actually treating the underlying condition, not just symptom management
• Polypharmacy challenges (stimulants + cataplexy treatment + comorbid psych meds)
• Collaboration with sleep specialists (interesting consult relationships)

How Klarity Health Supports Narcolepsy Prescribers

Here’s the traditional path: Spend $3,000-5,000/month on Google Ads for ‘psychiatrist near me,’ wait 6-12 months for SEO to generate traffic, pay a consultant to manage your Psychology Today profile, field calls from unqualified leads, deal with no-shows, and hope you eventually build a patient panel.

Patient acquisition for psychiatric care typically costs $200-500+ per qualified patient when you factor in ad spend, consultant fees, time spent on intake calls, and failed marketing attempts. And that’s assuming you have the expertise and patience to run marketing campaigns while also, you know, practicing medicine.

Klarity Health takes a different approach:

Pay Only When You See Patients

• No upfront marketing spend
• No monthly subscription fees
• Standard listing fee per new patient appointment
• You control your schedule — only pay when patients actually book

Pre-Qualified Patient Flow

• Patients matched to your specialty and availability before they reach you
• Diagnosis already confirmed (sleep study documentation verified)
• Both insurance and cash-pay patient options
• No time wasted on ‘I’m just looking’ calls

Built-In Telehealth Infrastructure

• HIPAA-compliant video platform (no separate EMR/telehealth costs)
• EPCS-enabled e-prescribing integrated
• Automated PDMP checks in supported states
• Documentation templates for narcolepsy management
• Billing support for insurance claims

Compliance Handled

• State-by-state scope of practice guidance
• Collaborative agreement templates for restricted-practice states (TX, FL, PA)
• Regular updates on DEA rule changes
• Malpractice insurance partnerships (providers treating controlled-substance patients)

The Economics Make Sense

Instead of gambling $5,000/month on marketing with uncertain ROI, you pay only when you see a qualified patient. If a new narcolepsy patient books with you, you pay our listing fee — but you immediately start earning $100-150 per visit, and that patient will likely generate $400-1,800 in annual revenue.

Guaranteed ROI: You know exactly what patient acquisition costs, and you only pay when someone actually shows up. No wasted ad spend on clicks that don’t convert. No SEO investment that takes a year to bear fruit.

Why Narcolepsy Patients Choose Klarity

• They can’t find local specialists (or wait times are 6+ months)
• They’re moving states and need continuity of care
• They travel frequently and need flexible scheduling
• Previous provider stopped accepting their insurance
• They prefer telehealth for convenience and safety (sleep attacks make driving risky)

Our patient pool includes people actively searching for narcolepsy medication management — not just general ‘mental health’ seekers who might need three sessions before revealing they want a one-time Xanax prescription.

Frequently Asked Questions

Can psychiatrists prescribe Adderall for narcolepsy via telehealth?

Yes, in most states. The federal DEA waiver (extended through end of 2025) allows prescribing Schedule II controlled substances via telehealth without an initial in-person exam. You must be licensed in the patient’s state and follow state telemedicine laws. Florida is the main exception — state law prohibits Schedule II prescribing via telehealth for non-psychiatric conditions (use modafinil instead, or require in-person visit).

What’s the difference between narcolepsy and ADHD prescribing?

Clinically similar (both often use stimulants), but narcolepsy:

• Requires objective diagnosis (sleep study confirmation)
• May need higher stimulant doses
• Often involves combination therapy (stimulant + sodium oxybate)
• Carries different safety concerns (sleep attacks while driving vs. ADHD inattention)
• May have better insurance coverage (narcolepsy coded as medical condition, not mental health)

Do PMHNPs need special certification to treat narcolepsy?

No special certification required, but you must:

• Practice within your state’s scope (collaborative agreement if required)
• Have education/experience in sleep medicine and pharmacology
• Follow state prescribing restrictions (e.g., Texas NPs cannot prescribe Schedule II for narcolepsy)
• Document competence in your area of practice

How do I verify a narcolepsy diagnosis via telehealth?

Request documentation from the patient’s sleep specialist:

• Polysomnography (overnight sleep study) report
• Multiple Sleep Latency Test (MSLT) showing mean sleep latency <8 minutes and/or presence of SOREMPs
• Diagnosis of narcolepsy type 1 (with cataplexy) or type 2
• If documentation unavailable, refer patient to sleep specialist for diagnostic workup before initiating treatment

What if a patient’s pharmacy can’t fill their stimulant prescription due to shortages?

Common issue with Adderall shortage. Options:

• Send prescription to alternative pharmacy (patient calls around)
• Switch to different stimulant (e.g., Adderall → methylphenidate)
• Use non-stimulant alternative (modafinil, Sunosi, Wakix)
• Document shortage and reason for medication change in chart
• Communicate with patient about ongoing supply issues and flexibility

Can I treat narcolepsy patients in multiple states?

Yes, but you must:

• Hold active medical license in each state where patients reside
• Register with DEA in those states (or have appropriate federal registration)
• Understand each state’s scope of practice and telehealth laws
• Maintain separate PDMP access for each state
• Consider Interstate Medical Licensure Compact for faster multi-state licensing (psychiatrists)

What’s the malpractice risk of prescribing controlled substances via telehealth?

Risk is comparable to in-person if you:

• Document thorough evaluation and clinical rationale
• Check PDMP before each prescription
• Use structured follow-up protocols
• Obtain informed consent for telehealth and controlled substances
• Stay current with DEA/state rule changes
• Follow standard of care (same as you would in-person)

Most malpractice carriers cover telehealth services; confirm your policy includes controlled-substance prescribing via telemedicine.

The Bottom Line: Should You Do This?

If you’re a psychiatrist or PMHNP looking to:

• Work within a clear clinical protocol (less ambiguity than therapy-focused practice)
• See patients who desperately need your expertise (genuine access problem)
• Build a stable patient panel with predictable visit schedules
• Leverage telehealth efficiently (short visits, high volume potential)
• Avoid the marketing treadmill (platform handles patient acquisition)

Treating narcolepsy via telehealth makes both clinical and business sense.

The regulatory landscape is navigable — especially if you’re a psychiatrist with full prescribing authority or a PMHNP in a full-practice state. Even in restricted states, collaborative practice models work fine with the right physician partnership.

The patient need is real and growing. The medication shortage has only made access worse, driving more people to telehealth solutions. And unlike treating depression or anxiety (where you’re one of thousands of options), becoming the ‘narcolepsy-friendly’ psychiatrist makes you genuinely scarce and valuable.

Ready to explore this? Join Klarity Health’s provider network and start seeing narcolepsy patients within weeks — not months or years. We handle the patient acquisition, you handle the medicine. You control your schedule, we control the costs.

No upfront marketing spend. No gambling on SEO. No wondering if that $500 ad campaign will generate a single qualified patient. Just straightforward, pay-per-appointment economics where you know exactly what you’re getting.

The patients are waiting. The demand is there. The question is: Are you ready to meet it?

Citations and Sources

1. Axios – ‘COVID-era telehealth prescribing extended again’ (Nov 18, 2024). Reports DEA/HHS extension of controlled-substance telehealth waiver through end of 2025. www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall

2. Texas Medical Board – ‘Who can prescribe Schedule II drugs under physician delegation?’ Official guidance confirming Texas NP/PA limitations on Schedule II prescribing (hospital/hospice only for outpatients). www.tmb.state.tx.us/274-who-can-prescribe-schedule-ii-drugs-under-physician-delegation

3. California Board of Registered Nursing – AB 890 Implementation (updated 2024). Details on 103 NP and 104 NP certification pathways and timeline. www.rn.ca.gov/practice/ab890.shtml

4. Florida Statutes – Section 464.012, Nurse Practice Act (2021). Specifies 7-day Schedule II prescription limit for APRNs and psychiatric nurse exception. www.flsenate.gov/Laws/Statutes/2021/Chapter464/All

5. Rivkin Radler Law Blog – ‘New Law Allows Experienced NPs to Practice Independently in NY’ (Apr 13, 2022). Summarizes NY Education Law amendments removing collaborative agreement requirement after 3,600 hours. www.rivkinrounds.com/2022/04/new-law-allows-experienced-nps-to-practice-independently-in-ny/

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20and,person%20doctor%27s%20visit%20for%20the
• https://natlawreview.com/article/new-florida-law-allows-telemedicine-prescribing-controlled-substances#:~:text=controlled%20substances%20via%20telemedicine%2C%20with,more%20on
• https://www.ilga.gov/legislation/ILCS/details?ActID=1312&ActName=Nurse+Practice+Act.&ChapAct=225+ILCS+65%2F&Chapter=&ChapterID=24&MajorTopic=&Print=True&SeqEnd=17850000&SeqStart=16500000#:~:text=,drugs%2C%20such%20as
• https://www.ilga.gov/legislation/ILCS/details?ActID=1312&ActName=Nurse+Practice+Act.&ChapAct=225+ILCS+65%2F&Chapter=&ChapterID=24&MajorTopic=&Print=True&SeqEnd=17850000&SeqStart=16500000#:~:text=,require%20a%20physician%20name%3B
• https://www.rivkinrounds.com/2022/04/new-law-allows-experienced-nps-to-practice-independently-in-ny/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship
• https://www.rn.ca.gov/practice/ab890.shtml#:~:text=%2A%20103%20NP%20,focus%20of%20their%20National%20Certification
• https://www.rn.ca.gov/practice/ab890.shtml#:~:text=Please%20note%2C%20the%20law%20requires,certify%20104%20NPs%20until%202026
• https://www.tmb.state.tx.us/274-who-can-prescribe-schedule-ii-drugs-under-physician-delegation#:~:text=1.%20in%20a%20hospital%20facility,has%20elected%20to%20receive%20hospice
• https://www.flsenate.gov/Laws/Statutes/2021/Chapter464/All#:~:text=match%20at%20L1566%20limit%20the,455
• https://www.pacodeandbulletin.gov/Display/pacode?file=%2Fsecure%2Fpacode%2Fdata%2F049%2Fchapter21%2Fs21.284.html#:~:text=,may%20not%20delegate%20prescriptive%20authority